Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Chiang Mai Ram Medical Business PCL EV-to-EBITDA?
Chiang Mai Ram Medical Business PCLBKK:CMR-R +0.78%36 EV-to-EBITDA is 2.56 as of Sep. 06, 2026, which is 84% below its 10-year median of 16.37. GuruFocus rates BKK:CMR-R with a GF Score™ of 36/100 and a GF Value™ of ฿0.55 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 513 Healthcare Providers & Services companies, Chiang Mai Ram Medical Business PCL ranks better than 94.74% on this metric.
BKK:CMR-R'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.45 Med: 16.37 Max: 55.82
Current: 2.56
During the past 13 years, the highest EV-to-EBITDA of Chiang Mai Ram Medical Business PCL was 55.82. The lowest was 2.45. And the median was 16.37.
BKK:CMR-R's EV-to-EBITDA is ranked better than 94.74% of 513
companies
in the Healthcare Providers & Services industry
Industry Median: 10.51
vs BKK:CMR-R: 2.56
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Chiang Mai Ram Medical Business PCL (BKK:CMR-R) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Chiang Mai Ram Medical Business PCL's PE Ratio (TTM) for today is calculated as:
Chiang Mai Ram Medical Business PCL's share price for today is ฿1.30.
Chiang Mai Ram Medical Business PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.591.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chiang Mai Ram Medical Business PCL EV-to-EBITDA Chart
BKK:CMR-R vs HCA, THC, EHC: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Chiang Mai Ram Medical Business PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chiang Mai Ram Medical Business PCL EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Chiang Mai Ram Medical Business PCL's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Chiang Mai Ram Medical Business PCL's EV-to-EBITDA falls into.
Chiang Mai Ram Medical Business PCL's current Enterprise Value is ฿7,450 Mil.
Chiang Mai Ram Medical Business PCL's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿2,910 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chiang Mai Ram Medical Business PCL (BKK:CMR-R) has a EV-to-EBITDA of 2.56 as of Sep. 06, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Chiang Mai Ram Medical Business PCL. This is 84% below median its historical median of 16.37. Over the past decade, Chiang Mai Ram Medical Business PCL's EV-to-EBITDA has ranged from 2.45 to 55.82. According to the industry distribution chart, Chiang Mai Ram Medical Business PCL ranks #27 out of 513 companies in the Healthcare Providers & Services industry, placing it in the top 5.3%.
Is Chiang Mai Ram Medical Business PCL's EV-to-EBITDA too high?
Chiang Mai Ram Medical Business PCL's current EV-to-EBITDA of 2.56 is 84% below median its 10-year median of 16.37. Over the past 10 years, this metric has ranged from a low of 2.45 to a high of 55.82. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.51. Chiang Mai Ram Medical Business PCL's value of 2.56 is 75.6% below this industry median. Based on the distribution chart, Chiang Mai Ram Medical Business PCL ranks #27 out of 513 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Chiang Mai Ram Medical Business PCL has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chiang Mai Ram Medical Business PCL's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Chiang Mai Ram Medical Business PCL ranks #27 out of 513 companies for EV-to-EBITDA. This places Chiang Mai Ram Medical Business PCL in the top 5% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 10.51. Chiang Mai Ram Medical Business PCL's value of 2.56 is 75.6% below this benchmark. Historically, Chiang Mai Ram Medical Business PCL's own EV-to-EBITDA has ranged from 2.45 to 55.82 over the past decade. While the company's 10-year median is 16.37 vs. the industry median of 10.51, Chiang Mai Ram Medical Business PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.51, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chiang Mai Ram Medical Business PCL's current EV-to-EBITDA of 2.56 is 75.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Chiang Mai Ram Medical Business PCL. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chiang Mai Ram Medical Business PCL's current EV-to-EBITDA is 2.56, which is 84% below median its own 10-year median of 16.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chiang Mai Ram Medical Business PCL stock overvalued right now?
Based on GuruFocus' analysis, Chiang Mai Ram Medical Business PCL (BKK:CMR-R) is currently considered Significantly Overvalued. The stock's GF Value™ is ฿0.55, compared to a current price of ฿1.30 — trading 136.4% above its estimated fair value. The current EV-to-EBITDA is 2.56, which is 84% below median its 10-year median of 16.37 and 75.6% below the Healthcare Providers & Services industry median of 10.51. Chiang Mai Ram Medical Business PCL's overall GF Score™ is 36/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Chiang Mai Ram Medical Business PCL (BKK:CMR-R), the current EV-to-EBITDA is 2.56 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chiang Mai Ram Medical Business PCL (BKK:CMR-R) Overvalued in 2026?
Based on GuruFocus' analysis, Chiang Mai Ram Medical Business PCL stock appears to be overvalued.
The current stock price of ฿1.30 is trading 136.4% above its estimated GF Value™ of ฿0.55.
GuruFocus considers Chiang Mai Ram Medical Business PCL to be Significantly Overvalued.
Key valuation signals for BKK:CMR-R:
EV-to-EBITDA: 2.56 (84% below median its 10-year median of 16.37)
GF Value™: ฿0.55 vs. price of ฿1.30 (136.4% above fair value)
Industry Position: 75.6% below the Healthcare Providers & Services median (#27 of 513)
No single metric tells the full story. See the BKK:CMR-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chiang Mai Ram Medical Business PCL is a Thailand-based company. It provides medical services in the nature of General Hospital, Hospital in Social Security, and the national health security office systems. It offers various medical services including a Dental center, X-ray mobile for a checkup, CT Multislice, Cardiac Catheterization Center, Back pain center, Gynecologic Cancer center, Physical therapy, Operating theatres, Laboratory, Ambulance Services, and Health checkup center, and others. The company provides medical services through the Lanna Hospital.
36GF Score
Get the complete analysis for BKK:CMR-R
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:CMR-R has been successfully added to your 
